R.I. Commerce board approves $10M incentive package for Mass.-based biotech firm

Updated at 4:30 p.m. on Oct. 31

Christopher Allen

10/31/2024

techwaycrop — MASSACHUSETTS-BASED BIOTECHNOLOGY FIRM Organogenesis on Thursday was approved for $10 million in tax incentives by R.I. Commerce Corp. in order to establish a manufacturing facility at the former Rubius Therapeutics facility in Smithfield. This a screenshot of the property listing on Loopnet.com. / COURTESY THE DAVIS COS.

PROVIDENCE – R.I. Commerce Corp.’s board of directors on Thursday unanimously approved $10 million in Rebuild Rhode Island tax credits to Organogenesis Holdings Inc. of Canton, Mass., part of an incentive package to establish a manufacturing operation at the former Rubius Therapeutics facility in Smithfield. In addition, the R.I. Life Sciences Hub approved a $5

Already a Subscriber? Log in

To Continue Reading This Article

Become a Providence Business News subscriber and get immediate access to all of our premier content and much more.

Learn More and Become a Subscriber